FWI
VRTX icon

Facet Wealth Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Facet Wealth Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$275K Buy
+616
New +$287K ﹤0.01% 274
2025
Q4 		– Sell
-691
Closed -$271K – 305
2025
Q3 		$271K Buy
691
+158
+30% +$66K 0.01% 174
2025
Q2 		$244K Buy
+533
New +$246K 0.01% 160

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Facet Wealth Inc's VRTX Position: Q1 2026 in Review

Facet Wealth Inc opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 616 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #274 among its holdings. This is a return to the name: Facet Wealth Inc previously reported a position in VRTX as recently as Q3 2025.

Facet Wealth Inc first reported a position in VRTX in Q2 2025 and has held it in 3 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Facet Wealth Inc held 616 shares of Vertex Pharmaceuticals worth $275K as of Q1 2026.
  • Vertex Pharmaceuticals was a new Facet Wealth Inc position in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Facet Wealth Inc's portfolio in Q1 2026, its #274 holding.
  • Facet Wealth Inc first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Facet Wealth Inc's 13F filing for Q1 2026, filed 7 May 2026.